Nanomedicine, Vol 509

Elsevier Science and Technology, July 2012, Pages: 470

This volume in the Methods in Enzymology series comprehensively covers Infectious Diseases, Immunotheraphy, Gene Medicine, Diagnostics and Toxicology of Nanomedicine. With an international board of authors, this volume is split into sections that cover subjects such as Nanomedicines in Immunotherapy, Nanomedicine toxicity, and Diagnostic Nanomedicine.

- Comprehensively covers infectious diseases, immunotherapy, gene medicine, diagnostics, and toxicology of nanomedicine
- International board of authors
- Split into sections that cover subjects such as Nanomedicines in Immunotherapy, Nanomedicine Toxicity, and Diagnostic Nanomedicine

Antiviral Nanomedicines

Enhanced antiviral activity of acyclovir loaded into nanoparticles

Gold manno-Glyconanoparticles for Intervening in HIV gp120 Carbohydrate-Mediated Processes
Nanoparticle mediated targeted delivery of antiretrovirals to the brain

Antibacterial Nanomedicines

Antibacterial activity of doxycycline-loaded nanoparticles
Antimicrobial properties of electrically formed elastomeric polyurethane-copper oxide nanocomposites for medical and dental applications

Nanomedicines in Immunotherapy

Gastrointestinal delivery of anti-inflammatory nanoparticles
Chitosan-based nanoparticles as a Hepatitis B antigen delivery system
Targeting nanoparticles to dendritic cells for immunotherapy

Diagnostic Nanomedicine

Design and fabrication of N-Alkyl-polyethylenimine stabilized iron oxide nanoclusters for gene delivery
Protein-Carbon Nanotube Sensors: Single Platform Integrated Micro Clinical Lab for Monitoring Blood Analytes

Nanomedicine Toxicity

Investigating the toxic effects of iron oxide nanoparticles
Cytotoxicity of Gold Nanoparticles

Antifibrotic Nanomedicine

Design of target-seeking antifibrotic compounds

Genetic Nanomedicine

Cell-penetrating peptide-based systems for nucleic acid delivery: A biological and biophysical approach
Multifunctional envelope-type nano-device (MEND) for organelle targeting via a step-wise membrane fusion process
Lipopolyplexes as nanomedicines for therapeutic gene delivery
Interfering nanoparticles (iNOPs) for silencing microRNAs
Genetic Nanomedicine: Gene Delivery by Targeted Lipoplexes

Customers who bought this item also bought

• Nanobiotechnology Applications, Markets and Companies
• Update on Polymer Based Nanomedicine
• Gene Therapy - Technologies, Markets and Companies
• Antiviral Therapeutics - Technologies, Markets and Companies
• RNAi - Technologies, Markets and Companies
• Cell Therapy - Technologies, Markets and Companies
• Biomarkers - Technologies, Markets and Companies
• Nanomaterials in Drug Delivery, Imaging, and Tissue Engineering
• Neuroprotection - Drugs, Markets and Companies
• Environmental Toxicity of Nanoparticles